{"&cites=5427817888518646484&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673608610399","authors":["RJ Motzer","RJ Motzer B Escudier","RJ Motzer B Escudier S Oudard","RJ Motzer B Escudier S Oudard TE Hutson","RJ Motzer B Escudier S Oudard TE Hutson C Porta…"],"year":2008,"numCitations":3182,"pdf":"http://www.academia.edu/download/53999404/s0140-6736_2808_2961039-920170728-7660-zx8w1m.pdf","citationUrl":"http://scholar.google.com/scholar?cites=8449425975912964334&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:7iBAeihkQnUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8449425975912964334&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier","p":1,"exp":1596898399399},{"title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","url":"http://s-space.snu.ac.kr/handle/10371/77398","authors":["CN Sternberg","CN Sternberg ID Davis","CN Sternberg ID Davis J Mardiak…"],"year":2010,"numCitations":2448,"pdf":"http://s-space.snu.ac.kr/bitstream/10371/77398/1/Sternberg-2010-Pazopanib%20in%20Locally.pdf","citationUrl":"http://scholar.google.com/scholar?cites=17868513553253356300&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:DFPrvWe2-fcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17868513553253356300&hl=en&as_sdt=2005&sciodt=0,5","publication":"s-space.snu.ac.kr"},{"title":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673611616139","authors":["BI Rini","BI Rini B Escudier","BI Rini B Escudier P Tomczak","BI Rini B Escudier P Tomczak A Kaprin","BI Rini B Escudier P Tomczak A Kaprin C Szczylik…"],"year":2011,"numCitations":1695,"citationUrl":"http://scholar.google.com/scholar?cites=3547505814206124423&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:h5FjFr5FOzEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3547505814206124423&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"EAU guidelines on renal cell carcinoma: the 2010 update","url":"https://www.sciencedirect.com/science/article/pii/S0302283810005919","authors":["B Ljungberg","B Ljungberg NC Cowan","B Ljungberg NC Cowan DC Hanbury","B Ljungberg NC Cowan DC Hanbury M Hora…"],"year":2010,"numCitations":1557,"pdf":"http://www.aamed.eco.br/imagens/pdf/EAU-Guidelines-on-Renal-Cell-Carcinoma-the-2010-Update.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13647781770707630156&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:THgUHzapZr0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13647781770707630156&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results …","url":"https://confkhalifa.com/trainingkhalifa/wp-content/uploads/2017/05/DP-2-LCA-ARTICLE-The%CC%81o-PEZEL-CB-avril-2017-anglais.pdf","authors":["DYC Heng","DYC Heng W Xie","DYC Heng W Xie MM Regan","DYC Heng W Xie MM Regan MA Warren…"],"year":2009,"numCitations":1433,"pdf":"https://confkhalifa.com/trainingkhalifa/wp-content/uploads/2017/05/DP-2-LCA-ARTICLE-The%CC%81o-PEZEL-CB-avril-2017-anglais.pdf","citationUrl":"http://scholar.google.com/scholar?cites=4181130477325190870&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:1gaHPARcBjoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4181130477325190870&hl=en&as_sdt=2005&sciodt=0,5","publication":"confkhalifa.com"},{"title":"Renal cell carcinoma","url":"https://www.sciencedirect.com/science/article/pii/S0140673609602294","authors":["BI Rini","BI Rini SC Campbell","BI Rini SC Campbell B Escudier"],"year":2009,"numCitations":1387,"pdf":"https://oncologypro.esmo.org/content/download/233726/3944876/file/2019-ESMO-ESO-Course-Valencia-Renal-Cancer-Christoph-Oing.pdf","citationUrl":"http://scholar.google.com/scholar?cites=807962691249077211&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:23urc8l1NgsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=807962691249077211&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","authors":["RJ Motzer","RJ Motzer NM Tannir","RJ Motzer NM Tannir DF McDermott…"],"year":2018,"numCitations":1247,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","citationUrl":"http://scholar.google.com/scholar?cites=13898631485117911629&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:TVKDlrLb4cAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13898631485117911629&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Combining immunotherapy and targeted therapies in cancer treatment","url":"https://www.nature.com/articles/nrc3237","authors":["M Vanneman","M Vanneman G Dranoff"],"year":2012,"numCitations":1139,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3967236/","citationUrl":"http://scholar.google.com/scholar?cites=15625866808099638977&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wY5YlBI72tgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15625866808099638977&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study","url":"https://www.researchgate.net/profile/Akira_Sawaki/publication/51574214_Bevacizumab_in_Combination_With_Chemotherapy_As_First-Line_Therapy_in_Advanced_Gastric_Cancer_A_Randomized_Double-Blind_Placebo-Controlled_Phase_III_Study/links/0046351a370ef364cb000000/Bevacizumab-in-Combination-With-Chemotherapy-As-First-Line-Therapy-in-Advanced-Gastric-Cancer-A-Randomized-Double-Blind-Placebo-Controlled-Phase-III-Study.pdf","authors":["A Ohtsu","A Ohtsu MA Shah","A Ohtsu MA Shah E Van Cutsem","A Ohtsu MA Shah E Van Cutsem SY Rha…"],"year":2011,"numCitations":1077,"pdf":"https://www.researchgate.net/profile/Akira_Sawaki/publication/51574214_Bevacizumab_in_Combination_With_Chemotherapy_As_First-Line_Therapy_in_Advanced_Gastric_Cancer_A_Randomized_Double-Blind_Placebo-Controlled_Phase_III_Study/links/0046351a370ef364cb000000/Bevacizumab-in-Combination-With-Chemotherapy-As-First-Line-Therapy-in-Advanced-Gastric-Cancer-A-Randomized-Double-Blind-Placebo-Controlled-Phase-III-Study.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2478834432766478713&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:eYkNfsiWZiIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2478834432766478713&hl=en&as_sdt=2005&sciodt=0,5","publication":"researchgate.net"},{"title":"Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651074/","authors":["BI Rini","BI Rini S Halabi","BI Rini S Halabi JE Rosenberg…"],"year":2008,"numCitations":1022,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651074/","citationUrl":"http://scholar.google.com/scholar?cites=18273808260162582187&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:q_aWOMubmf0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18273808260162582187&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"}]}